Pseudomembranous Colitis Quiz

Check your symptoms and
find possible causes with AI for free

Worried about your symptoms?

Start the Pseudomembranous Colitis test with our free AI Symptom Checker.

This will help us personalize your assessment.

Shiba

By starting the symptom checker, you agree to the Privacy Policy and Terms of Use

Diarrhea

Stomachache

Have a fever

Stomachache gets worse when pressed

Bloating

Yellow eyes

Loose stool

Not seeing your symptoms? No worries!

What is Pseudomembranous Colitis?

An infection of the large intestine, typically following antibiotic use. The antibiotics kill both good and bad bacteria, disrupting the normal balance of gut flora.

Typical Symptoms of Pseudomembranous Colitis

Diagnostic Questions for Pseudomembranous Colitis

Your doctor may ask these questions to check for this disease:

  • Are you on antibiotics or have you recently taken any?
  • Do you have a fever?
  • Have you noticed any blood in your stool?
  • Have you noticed any yellowing of your eyes or skin?
  • Do you have any stomach or abdominal pain?

Treatment of Pseudomembranous Colitis

It's important to stop the antibiotics causing this infection. After that, another antibiotic that targets the infection is given to kill the harmful bacteria.

Reviewed By:

Maxwell J. Nanes, DO

Maxwell J. Nanes, DO (Emergency Medicine)

Dr Nanes received a doctorate from the Chicago College of Osteopathic Medicine and went on to complete a residency in emergency medicine at the Medical College of Wisconsin. There he trained at Froedtert Hospital and Children's Hospital of Wisconsin in the practice of adult and pediatric emergency medicine. He was a chief resident and received numerous awards for teaching excellence during his time there. | | After residency he took a job at a community hospital where he and his colleagues worked through the toughest days of the COVID-19 pandemic. |

Aiko Yoshioka, MD

Aiko Yoshioka, MD (Gastroenterology)

Dr. Yoshioka graduated from the Niigata University School of Medicine. He worked as a gastroenterologist at Saiseikai Niigata Hospital and Niigata University Medical & Dental Hospital before serving as the Deputy Chief of Gastroenterology at Tsubame Rosai Hospital and Nagaoka Red Cross Hospital. Dr. Yoshioka joined Saitama Saiseikai Kawaguchi General Hospital as Chief of Gastroenterology in April 2018.

From our team of 50+ doctors

Content updated on Sep 2, 2025

Following the Medical Content Editorial Policy

Was this page helpful?

Tell your friends about us.

We would love to help them too.

smily Shiba-inu looking

Think you might have
Pseudomembranous Colitis?

Try a symptom check test

How Ubie Can Help You

With a free 3-min Pseudomembranous Colitis quiz, powered by Ubie's AI and doctors, find possible causes of your symptoms.

This questionnaire is customized to your situation and symptoms, including the following personal information:

  • Biological Sex - helps us provide relevant suggestions for male vs. female conditions.

  • Age - adjusts our guidance based on any age-related health factors.

  • History - considers past illnesses, surgeries, family history, and lifestyle choices.

Your symptoms

Input your symptoms

Our AI

Our AI checks your symptoms

Your report

You get your personalized report

Your personal report will tell you

✔  When to see a doctor

✔︎  What causes your symptoms

✔︎  Treatment information etc.

People with similar symptoms also use Ubie's symptom checker to find possible causes

See full list

Symptoms Related to Pseudomembranous Colitis

Diseases Related to Pseudomembranous Colitis

FAQs

Q.

Still Hurting? Why Sulfamethoxazole-Trimethoprim is the Medical Next Step

A.

If your symptoms are not improving, sulfamethoxazole trimethoprim is often the next medical step because it blocks bacterial growth in two complementary ways and treats many stubborn infections, including UTIs, kidney infections, and certain skin infections like some MRSA, with improvement often seen in 48 to 72 hours when taken correctly. There are several factors to consider. See below for who should avoid it or adjust dosing, possible side effects and warning signs like severe rash or persistent diarrhea, important drug interactions, safety tips such as hydration and sun protection, and when to contact your doctor if there is no improvement by 72 hours.

References:

* Liu, W. X., et al. "Trimethoprim-sulfamethoxazole for the treatment of methicillin-resistant Staphylococcus aureus infections: a systematic review and meta-analysis." *Clinical Infectious Diseases*, vol. 63, no. 9, 2016, pp. 1184-1191.

* Ambrosioni, J., et al. "Trimethoprim-sulfamethoxazole for the treatment of Nocardia infections: an updated systematic review." *Clinical Infectious Diseases*, vol. 68, no. 9, 2019, pp. 1603-1614.

* Salzer, H., et al. "Trimethoprim-sulfamethoxazole for the treatment of Pneumocystis jirovecii pneumonia in non-HIV-infected patients." *Annals of Respiratory Medicine*, vol. 6, no. 1, 2022, pp. 1-8.

* Lipsky, B. A., et al. "The role of trimethoprim-sulfamethoxazole in the treatment of diabetic foot infections." *The American Journal of Medicine*, vol. 129, no. 10, 2016, pp. 1109-1115.

* Rusu, A., et al. "Trimethoprim-sulfamethoxazole: an update on its clinical utility." *Journal of Clinical Pharmacy and Therapeutics*, vol. 49, no. 4, 2024, pp. 509-520.

See more on Doctor's Note

Q.

Vancomycin Side Effects? Why Your Body Needs It & Medically Approved Next Steps

A.

Vancomycin is prescribed to fight serious Gram-positive infections such as MRSA and severe C. diff; side effects can include infusion reactions like Red Man Syndrome, kidney effects, rare hearing changes, GI upset with oral dosing, and true allergy, most of which are manageable with slow infusions and close lab monitoring. Know when to call your doctor or seek urgent care, keep all lab checks, stay hydrated, and do not stop early without medical advice; there are several factors to consider that can change your next steps, so see the complete guidance below.

References:

* Patel S, Palakodeti D, Marraffa E, Shah J, Nimmagadda M, DeSimone N, Javia A. Vancomycin in the 21st Century: A Reassessment of Its Role in the Treatment of Serious Gram-Positive Infections. J Clin Med. 2020 Apr 7;9(4):1043. PMID: 32268480.

* De Ryck S, De Coster I, Vanhooren G, Buyle F, Van de Velde J, Van Den Abeele AM. Vancomycin-Associated Nephrotoxicity and Ototoxicity: A Scoping Review. J Clin Med. 2021 Aug 26;10(17):3878. PMID: 34503799.

* Myers C, Chambers RM, Bhakta K, Huesgen E, Li J, Minard LV. Red Man Syndrome Secondary to Vancomycin: A Systematic Review. J Clin Med. 2020 Jul 14;9(7):2229. PMID: 32669466.

* Rybak MJ, Le J, Lodise JA, Levine DP, Bradley JS, Liu A, Mueller BA, Pai MP, Wong B, Gustafson JE, Coplin B, Swaminathan S, Waite EA, Van Schooneveld TC, Shields RK, Murray B, Guervil DJ, Wesolowski B, Rubino CM. Clinical Pharmacokinetics and Pharmacodynamics of Vancomycin: An Update. Clin Infect Dis. 2020 Nov 30;71(11):2949-2959. PMID: 33267597.

* Hamad MA, Alkhubaiz YA, Ali F, Madi M, Alhassan H, Hasan NA, Al-Awadhi R. Therapeutic Drug Monitoring of Vancomycin: A Systematic Review of Guidelines. J Clin Med. 2021 Jan 20;10(2):364. PMID: 33494793.

See more on Doctor's Note

Q.

Still Sick? Why Ceftriaxone Fails and Medically Approved Next Steps

A.

If you are still sick after ceftriaxone, there are several factors to consider; common reasons include a nonbacterial illness, resistant bacteria, too little or too short a course, an undrained source like an abscess, a different diagnosis, or antibiotic side effects such as C. diff. For timelines and condition-specific clues that can change your next steps, see the complete details below. Next steps are to contact your doctor for reassessment within 48 to 72 hours if you are not improving, get targeted tests and cultures to guide an antibiotic change or procedures if needed, and seek urgent care for red flags like severe abdominal pain, persistent high fever, bloody diarrhea, confusion, or trouble breathing; key details and exceptions are outlined below.

References:

* Marquez C, Chenard Z, Iannuzzi M. Multidrug-Resistant Gram-Negative Bacterial Infections: A Narrative Review of Current Therapeutic Options. Infect Dis Ther. 2023 Dec;12(12):2701-2720. doi: 10.1007/s40121-023-00913-9. Epub 2023 Oct 23. PMID: 37870935.

* Shi C, Wang J. Mechanisms of Antimicrobial Resistance and Rational Development of Novel Antimicrobial Agents. Microbiol Spectr. 2023 Feb 14;11(1):e0304322. doi: 10.1128/spectrum.03043-22. Epub 2023 Jan 26. PMID: 36768783.

* Palmer V, Chisholm SA, Unemo M. Update on treatment options for multi-drug resistant Neisseria gonorrhoeae. Ther Adv Infect Dis. 2022 Jan 10;9:20499361211068228. doi: 10.1177/20499361211068228. PMID: 35057053.

* Li H, Liu Y, Jin M. Extended-spectrum β-lactamases: resistance mechanism, epidemiology, and treatment. Microb Biotechnol. 2021 Jul;14(4):1413-1425. doi: 10.1111/1751-7915.13783. Epub 2021 Mar 18. PMID: 33744955.

* Tamma PD, Aitken SL, Bonomo RA, et al. Infectious Diseases Society of America 2020 Guidance on the Treatment of Antimicrobial-Resistant Gram-Negative Infections. Clin Infect Dis. 2021 Apr 8;72(7):e169-e192. doi: 10.1093/cid/ciaa1478. PMID: 32979261.

See more on Doctor's Note

Q.

Infection Not Clearing? Why Your Body Needs Clindamycin & Medically Approved Next Steps

A.

Clindamycin is a targeted antibiotic used when first-line treatments fail, such as with resistant bacteria, penicillin allergy, deep tissue infections, or anaerobic infections; you should start to feel better within 48 to 72 hours, complete the full course, and watch for severe diarrhea that could signal C. diff. If you are not improving, reconnect with your doctor for culture-guided therapy, possible imaging or abscess drainage, and urgent care for red flags; there are several factors to consider, and key details that can shape your next steps are explained below.

References:

* Finegold SM. Clindamycin Revisited: A Review of its Role in the Treatment of Anaerobic Infections. Clin Infect Dis. 2018 Sep 14;67(Suppl 2):S105-S110. doi: 10.1093/cid/ciy519. PMID: 30046647.

* Lewis K. Mechanisms of bacterial persistence and biofilm formation. Annu Rev Microbiol. 2017 Sep 8;71:405-421. doi: 10.1146/annurev-micro-090816-010355. PMID: 28594954.

* Spigaglia P, Facchin D, Gagliardi L, Scaramella R, Cirino P, Nardella M, Pantosti A. Clindamycin resistance in Staphylococcus aureus: mechanisms, prevalence, and therapeutic implications. Future Microbiol. 2018 Mar;13:307-318. doi: 10.2217/fmb-2017-0242. Epub 2018 Jan 10. PMID: 29329712.

* Conlon BP. Strategies to overcome bacterial persistence and multidrug resistance. Curr Opin Microbiol. 2020 Oct;57:114-121. doi: 10.1016/j.mib.2020.04.010. Epub 2020 May 4. PMID: 32332130.

* Domenech M, García-Rodríguez S, de la Fuente-Núñez C. Antibiofilm Strategies: Current Therapeutic Advances and New Targets. Antibiotics (Basel). 2021 Jun 25;10(7):777. doi: 10.3390/antibiotics10070777. PMID: 34208226; PMCID: PMC8300257.

See more on Doctor's Note

Q.

Is Your Gut Failing? Why C. Diff Persists & Your Medically Approved Next Steps

A.

C. diff often persists because a disrupted gut microbiome, hardy spores, repeat antibiotic exposure, and weakened immunity let it rebound; most people recover with the right treatment, but seek urgent care for severe abdominal pain, high fever, blood in the stool, dehydration, or worsening symptoms. Medically approved next steps include fidaxomicin or oral vancomycin (often as a taper), bezlotoxumab, and fecal microbiota transplant, along with prevention steps like strict handwashing, cautious antibiotic use, hydration, and discussing probiotics with your doctor. There are several factors to consider, and key details that could change your next step are explained below.

References:

* McDonald, L. C., et al. "Clinical practice guidelines for Clostridium difficile infection in adults and children: 2021 update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA)." *Clinical Infectious Diseases*, vol. 75, no. 1, 2022, pp. e1-e60. DOI: 10.1093/cid/ciab549.

* Im, G. Y., et al. "American College of Gastroenterology (ACG) Clinical Guideline: Fecal Microbiota Transplantation for Clostridioides difficile Infection." *The American Journal of Gastroenterology*, vol. 118, no. 5, 2023, pp. 805-822. DOI: 10.14309/ajg.0000000000002220.

* Smits, W. K., et al. "Molecular mechanisms of Clostridioides difficile recurrence." *Nature Reviews Microbiology*, vol. 21, no. 1, 2023, pp. 18-34. DOI: 10.1038/s41579-022-00782-z.

* Deshpande, A., & Jain, R. "Recurrent Clostridioides difficile Infection: Evolving Paradigms in Diagnosis and Management." *Infectious Disease Clinics of North America*, vol. 36, no. 3, 2022, pp. 643-659. DOI: 10.1016/j.idc.2022.05.003.

* O'Neal, M. A., & Crooks, J. A. "*Clostridioides difficile* and the Microbiome: Current Understanding of Pathogenesis and Recurrence." *Microorganisms*, vol. 10, no. 10, 2022, p. 1960. DOI: 10.3390/microorganisms10101960.

See more on Doctor's Note

Ubie is supervised by 50+ medical experts worldwide

Our symptom checker AI is continuously refined with input from experienced physicians, empowering them to make more accurate diagnoses.

Maxwell J. Nanes, DO

Maxwell J. Nanes, DO

Emergency Medicine

Waukesha Memorial Hospital, Waukesha Wisconsin, USA

Caroline M. Doan, DO

Caroline M. Doan, DO

Internal Medicine

Signify Health

Benjamin Kummer, MD

Benjamin Kummer, MD

Neurology, Clinical Informatics

Icahn School of Medicine at Mount Sinai

Charles Carlson, DO, MS

Charles Carlson, DO, MS

Psychiatry

U.S. Department of Veterans Affairs

Dale Mueller, MD

Dale Mueller, MD

Cardiothoracic and Vascular Surgery

Cardiothoracic and Vascular Surgery Associates

Ravi P. Chokshi, MD

Ravi P. Chokshi, MD

Obstetrics and gynecology

Penn State Health

Ubie is recognized by healthcare and tech leaders

Newsweek 2024

“World’s Best Digital
Health Companies”

Newsweek 2024

Google Play Best of 2023

“Best With AI”

Google Play Best of 2023

Digital Health Awards 2023

“Best in Class”

Digital Health Awards 2023 (Quarterfinalist)

Which is the best Symptom Checker?

Which is the best Symptom Checker?

Ubie’s symptom checker demonstrated a Top-10 hit accuracy of 71.6%, surpassing the performance of several leading symptom checkers in the market, which averaged around 60% accuracy in similar assessments.

Link to full study:

https://www.medrxiv.org/content/10.1101/2024.08.29.24312810v1

References